Progene Pharma Private Limited, a active private limited company, was established on 06 March 2006 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U24230MH2006PTC160270. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Haider Abbas Nazar Abbas Syed (Director), Amena Fatema Haider Abbas (Director). Past directors included Deepak Ravindernath Khanna, Akhtar Ali Ishaq Mulla, Rajendra Sriram Moily. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No. 308, 3Rd Floor, A Wing, Mayuresh Trade Centre, Plot No.4, Sector, -19,Vashi, Navi Mumbai, Maharashtra, 400703.
U24230MH2006PTC160270
160270
06 March 2006
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Progene Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Haider Abbas Nazar Abbas Syed | Director | 06 Mar 2006 | Current |
| Amena Fatema Haider Abbas | Director | 12 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Jul 2010 | Past |
| Pramod Abcsdd | Director | 28 Feb 2017 | Past |
| Pramod Abcsdd | Additional Director | 24 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 06 Jul 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Progene Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.97% increase. The company also saw a substantial improvement in profitability, with a 32.72% increase in profit. The company's net worth Soared by an impressive increase of 101.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Progene Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Progene Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Progene Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Progene Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Progene Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Progene Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Amena Fatema Haider Abbas was appointed as a Director was appointed as a Director on 12 Jan 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.
The activity Haider Abbas Nazar Abbas Syed was appointed as a Director was appointed as a Director on 06 Mar 2006 & has been associated with this company since 19 years 9 months . was completed.
Progress on Progene Pharma Private Limited was registered on 06 Mar 2006 with Roc Mumbai & aged 19 years 9 months as per MCA records. was documented.
The CIN of Progene Pharma Private Limited is U24230MH2006PTC160270.
Progene Pharma Private Limited is headquartered at Office No. 308, 3Rd Floor, A Wing, Mayuresh Trade Centre, Plot No.4, Sector, -19,Vashi, Navi Mumbai, Maharashtra, 400703.
Progene Pharma Private Limited was incorporated on 06 March 2006.
The current directors of Progene Pharma Private Limited are
The primary industry of Progene Pharma Private Limited is Hospital And Medical Care.
Progene Pharma Private Limited is unlisted.
The authorized capital of Progene Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Progene Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX